Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 13/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | CALML3 | P27482 | 1/20 | 0.48 |
| ▸ | SDHA | P31040 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13150711 | 1.00 | MAOA (0.52) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL1037132 | 0.91 | MAOA (0.54) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL10197587 | 0.91 | MAOA (0.54) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL3185665 | 0.86 | MAOA (0.54) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL1036787 | 0.86 | MAOA (0.54) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL1393051 | 0.85 | MAOA (0.56) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL1036057 | 0.85 | MAOA (0.47) | MAOAMAOBLMNAPTGS1CALML3 | |
| SCHEMBL12956120 | 0.85 | MAOA (0.47) | MAOAMAOBLMNAPTGS1CALML3 | |
| SCHEMBL13150707 | 0.84 | MAOA (0.52) | MAOACYP3A4CYP2C19MAOBLMNA | |
| SCHEMBL13150712 | 0.83 | MAOA (0.54) | MAOACYP3A4CYP2C19MAOBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1904489-B1 | PROCESS FOR THE SYNTHESIS OF TRIAZOLES | RIB X PHARMACEUTICALS INC (US) | 2011-01-26 | — | — | EP | disclosed |